Guidance on categorising certain clinical trials as ‘notifiable’.
Similar Posts
Access Generic Medicines Work Sharing Initiative
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
Mirvetuximab soravtansine approved to treat adult patients who have ovarian, fallopian tube or primary peritoneal cancer
The approval is supported by a study involving 453 adults with advanced platinum-resistant cancers of the ovary, fallopian tubes and the peritoneum that were FRα positive
MHRA reaffirms safety of childhood vaccination
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
UK clinical trial approval times twice as fast with AI and reforms
Patients receive earlier access to life-saving treatments as UK trial approval times cut in half from 91 to just 41 days.